AdKCNH2-G628S

N/A

Report date: 2025/04/20 20:00:03

Base Information

Drug NameAdKCNH2-G628S
Drug Alias NameAdKCNH2-G-628S
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionVoltage-gated potassium channel subunit Kv11.1 blockers
TargetsVoltage-gated potassium channel subunit Kv11.1
Therapy Area/IndicationsAtrial Fibrillation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Massachusetts
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Massachusetts Medical SchoolUniversity of Massachusetts
Active IndicationsN/A
Inactive IndicationsAtrial Fibrillation

Other Information

ATC CodeN/A
Related LinksN/A